article · Life
A crude hot aqueous extract of the medicinal plant Sutherlandia frutescens demonstrates broad antidiabetic activity across several disease hallmarks in laboratory cell models. Testing revealed modest inhibition of targets linked to postprandial hyperglycaemia, including carbohydrate breakdown, intestinal glucose uptake in Caco-2 cells, and protein glycation. In liver cell models, the extract spurred dose-dependent glucose consumption, while in insulin-resistant skeletal muscle cells, it restored glucose consumption from a depressed baseline back to near-normal levels. The plant extract also preserved pancreatic beta-cell survival under oxidative stress at concentrations starting at 12.5 micrograms per millilitre. Rather than acting strongly on a single target, the extract appears to operate as a multicomponent therapy that coordinates modest effects across interconnected metabolic pathways simultaneously.
Diabetes is a complex condition involving multiple metabolic failures, from elevated blood sugar to reduced insulin sensitivity and pancreatic tissue damage. Identifying natural products that gently regulate several of these mechanisms at once provides a scientific basis for developing multicomponent herbal therapies or novel combination treatments capable of addressing the multifaceted nature of metabolic disorders.
This work identifies Sutherlandia frutescens as a potential candidate for botanical antidiabetic formulations or source material for lead compounds targeting metabolic syndrome and type 2 diabetes. Pharmaceutical and nutraceutical product developers could utilise these mechanistic findings to design targeted natural therapeutics. However, this research is early-stage laboratory work conducted entirely in vitro, meaning further preclinical animal testing and clinical safety and efficacy trials are necessary before any commercial application.
AI-generated from the published abstract. Always read the original work before citing.
Several studies have suggested potential mechanisms through which Sutherlandia frutescens exerts antidiabetic effects, yet much of its therapeutic potential remains unexplored. This study aimed to provide greater insights into the antidiabetic capabilities and limitations of S. frutescens through the use of a comprehensive in vitro screening platform incorporating target-directed assays with automated image cytometry and analysis, where relevant. The antidiabetic effects of a crude hot aqueous extract of S. frutescens were assessed across well-characterised targets representing prominent hallmarks of diabetes: postprandial hyperglycaemia, insulin sensitivity, β-cell dysfunction, chronic inflammation and adipose tissue dysfunction. The findings revealed S. frutescens as a multicomponent therapeutic, with its individual target activities being relatively subtle and a few appearing novel. Notably, however, S. frutescens inhibited multiple targets relevant to postprandial hyperglycaemia—including carbohydrate digestion (29.1% and 26.4% inhibition for sucrose and maltose, respectively, at 500 µg/mL), intestinal glucose uptake in Caco-2 cells (between 9.51% and 20.92% reduction from 100 to 500 µg/mL) and protein glycation (23.2% inhibition at 200 µg/mL)—activities not previously documented in vivo. Glucose consumption in C3A hepatocytes showed a dose-dependent increase in glucose consumption from 12.5 to 100 µg/mL. Glucose consumption was reduced in palmitic acid-induced insulin-resistant L6 skeletal muscle cells from 100% to 69.57%, while 50 µg/mL S. frutescens restored it to 97.84%. S. frutescens also enhanced INS-1 β-cell survival under oxidative stress at concentrations as low as 12.5 µg/mL. The integration of automated image cytometry and analysis provides a novel approach with which to characterise its antidiabetic properties and elucidate its potential molecular mechanisms. Overall, S. frutescens is shown to impact several interrelated mechanisms simultaneously, suggesting that the coordinated modulation of multiple pathways may contribute to its overall biological activity. Whether these effects are additive or synergistic remains to be determined.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3390/life16081348
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
